Unresectable Alveolar Soft Part Sarcoma
specificAn alveolar soft part sarcoma that is not amenable to surgical resection.
13
Centers
15
Active Trials
—
Cancer Funding
Top Centers for Unresectable Alveolar Soft Part Sarcoma(13)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 72.9 |
| 2 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center | 72.9 |
| 3 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 50.4 |
| 4 | NCI Comprehensive Active Research Program | 50.4 |
| 5 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 50.4 |
| 6 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 50.4 |
| 7 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 50.4 |
| 8 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 50.4 |
| 9 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 50.4 |
| 10 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 50.4 |
| 11 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 50.4 |
| 12 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 50.4 |
| 13 | Boston University Cancer CenterBoston, MA Active Research Program | 50.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →